gm-csf
Showing 1 - 25 of 81
Objective Response Rate Trial in Wuhan (GM-CSF)
Recruiting
- Objective Response Rate
- GM-CSF
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Feb 25, 2023
Neuroblastoma Trial in New York (dietary supplement, drug, biological)
Recruiting
- Neuroblastoma
- β-glucan
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 5, 2022
Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)
Active, not recruiting
- Neuroblastoma
- Hu3F8
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 1, 2022
NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Carcinoma Breast
- Vinorelbine
- +4 more
-
Suzhou, ChinaSecond Affiliated Hospital of Soochow University
Oct 29, 2022
Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)
Recruiting
- Recurrent Osteosarcoma
- humanized anti-GD2 antibody
- GM-CSF
-
Los Angeles, California
- +2 more
Dec 22, 2022
Colorectal Tumors Trial in Xiamen (hypofractionation Radiotherapy, sintilimab, GM-CSF)
Recruiting
- Colorectal Neoplasms
- hypofractionation Radiotherapy
- +3 more
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Mar 28, 2022
Glioma, Malignant Trial in Bangkok (ERC1671, GM-CSF, Cyclophosphamide)
Not yet recruiting
- Glioma, Malignant
- ERC1671
- +3 more
-
Bangkok, Vadhana, ThailandBumrungrad International Hospital
May 9, 2022
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Metastatic Melanoma Trial in Louisville (Ipilimumab, GM-CSF)
Completed
- Metastatic Melanoma
- Ipilimumab
- GM-CSF
-
Louisville, KentuckyJames Graham Brown Cancer Center
Oct 22, 2021
Advanced Refractory Solid Tumors Trial in China (Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF)
Recruiting
- Advanced Refractory Solid Tumors
- Hypofractionated radiotherapy
- +3 more
-
Beijing, China
- +15 more
Aug 8, 2022
Peripheral Artery Disease (PAD) Trial in Atlanta (GM-CSF, Placebo)
Recruiting
- Peripheral Artery Disease (PAD)
- GM-CSF
- Placebo
-
Atlanta, GeorgiaEmory University Hospital
Oct 8, 2021
Pediatric Sepsis-induced MODS Trial in United States (GM-CSF)
Active, not recruiting
- Pediatric Sepsis-induced MODS
- GM-CSF
-
Los Angeles, California
- +7 more
Feb 24, 2022
Critical Injury (Trauma) in Children Trial in United States (GM-CSF)
Completed
- Critical Injury (Trauma) in Children
- GM-CSF
-
Aurora, Colorado
- +7 more
Feb 24, 2022
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,
Active, not recruiting
- Ovarian Cancer
- +2 more
- GM-CSF
- +2 more
-
Boston, Massachusetts
- +3 more
Jan 25, 2022
Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)
Terminated
- Neuroblastoma
- antibody ch14.18
- +4 more
-
Cologne, GermanyUniversity of Cologne
Nov 3, 2022
Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)
Completed
- Mantle Cell Lymphoma
- Lymphoma, Mantle Cell
- EPOCH-R
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 4, 2023
Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)
Terminated
- Solid Tumors
- +2 more
- IBI188
- +5 more
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Oct 3, 2022
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome Trial in United States (GM-CSF, Placebo)
Not yet recruiting
- Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome
- GM-CSF
- Placebo
-
Little Rock, Arkansas
- +25 more
May 8, 2022
Breast Cancer Trial in United States (NeuVax vaccine, Trastuzumab, GM-CSF)
Completed
- Breast Cancer
- NeuVax vaccine
- +2 more
-
Santa Monica, California
- +23 more
Sep 15, 2022
Neuroblastoma (NB) Trial in New York (Irinotecan, temozolomide, Hu3F8)
Active, not recruiting
- Neuroblastoma (NB)
- Irinotecan
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 19, 2021
Prostate Cancer Trial in Madison (pTVG-HP, Nivolumab, GM-CSF)
Active, not recruiting
- Prostate Cancer
- pTVG-HP
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Feb 7, 2022